Filing Flows › Comparisons › CRWV vs SNPS
CoreWeave vs Synopsys: CRWV and SNPS compared
CoreWeave is the larger company: $2.6B of revenue in its latest quarter (Q2 2026) against $2.5B for Synopsys (Q3 FY26). CoreWeave is growing faster (+112% against +42% a year earlier). Synopsys is more profitable, with an operating margin of 14.4% against -1.9%.
Where the money goes: CRWV and SNPS
CoreWeave (CRWV) · Q2 2026
CoreWeave, Q2 2026: revenue $2.6B (+112% year over year), operating margin -1.9%, net loss $626M, operating cash flow $679M. The chart follows the revenue to costs, profit and cash.
Synopsys (SNPS) · Q3 FY26
Synopsys, Q3 FY26: revenue $2.5B (+42% year over year), operating margin 14.4%, net earnings $546M, operating cash flow $813M. The chart follows the revenue to costs, profit and cash.
| CoreWeave (CRWV) | Synopsys (SNPS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 FY26 |
| Revenue | $2.6B | $2.5B |
| Revenue growth, Y/Y | +112% | +42% |
| Gross margin | — | 72.6% |
| Operating margin | -1.9% | 14.4% |
| Net earnings | −$626M | $546M |
| Net margin | -24.3% | 22.0% |
| Operating cash flow | $679M | $813M |
| Free cash flow | — | $746M |
| Market value | $25.1B | $87.0B |
| P/E | — | 80.9× |
| Analysts’ mean target | $131.53 | $586.95 |
Where the revenue comes from
Synopsys
- Products: $1.7B (67%)
- Maintenance and service: $809M (33%)
Questions
Which is bigger, CoreWeave or Synopsys?
CoreWeave is the larger company: $2.6B of revenue in its latest quarter (Q2 2026) against $2.5B for Synopsys (Q3 FY26).
Is CoreWeave or Synopsys growing faster?
CoreWeave is growing faster (+112% against +42% a year earlier).
Which is more profitable, CoreWeave or Synopsys?
Synopsys is more profitable, with an operating margin of 14.4% against -1.9%.
More: CoreWeave earnings · how CoreWeave makes money · Synopsys earnings · how Synopsys makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 26, 2026). Fiscal quarters can end on different dates. Not investment advice.